- California charges taxpayers twice as much as Florida and delivers worse services.
- The true cost of charging an EV is equivalent to $17.33-per-gallon gasoline — but the EV owner pays less than 7% of that.
- Alvin Hanson: “world population will soon fall fast, and then unless we achieve full AGI or end aging by then, our total world economic capacity will also fall, with scale economies and innovation rates both falling roughly in proportion.”
- How to avoid high drug costs for patients: Let government buy the patents and put them in the public domain.
- Only 1 percent of Americans are both uninsured and lack A opportunity to enroll in subsidized coverage. This entire Health Affairs piece by Brian Blase is recommended.
Category: Cost of Healthcare
The Case for Medicare Advantage
Medicare Advantage enrollees experience lower rates of hospital admission and lower rates of expensive and ineffective medical procedures in the last few months of life.
Wednesday Links
- Life expectancy for men in the U.S. falls to 73 years — six years less than for women.
- Noah Smith lauds Singapore but neglects to mention Medisave accounts.
- What discount rate should be used in evaluating changes in health policies?
- Should medical screenings be based on cost/benefit analysis or on the patient’s willingness to pay?
- A tribute to Vernon Smith – long time friend of the Goodman Institute.
- Does the case for a free society depend on the existence of free will?
Should Employers Fund Rare Disease Research and Therapies?
Included in Friday Links (November 10) was the title, “Would coverage for gene therapies make employer-based health insurance unaffordable?” That raises an important question: How much should employers (and employees) be required to pay for hyper-expensive therapies very few people need? A related question: should the purpose of employee health coverage be to recruit and retain workers or fund rare disease research and therapies?